« Back
Home /
CDK9-IN-1

CDK9-IN-1

Manufacturer	MedChem Express
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Amount	10mM/1mL
Item no.	HY-13231-10mM
Targets	CDK; HIV
CASRN	1415559-43-1
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	CDK9-IN-1 is a novel, selective CDK9 inhibitor for the treatment of HIV infection, with an IC50 of 39 nM for CDK9/CycT1, extracted from reference, compound 87.
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	COVID-19-anti-virus
MolecularWeight	499.54
Clinical_Information	No Development Reported
Manufacturers Research_Area	Infection
Solubility	DMSO : 100 mg/mL (ultrasonic)
Manufacturers Target	CDK; HIV
Isoform	CDK9; HIV-1
Pathway	Anti-infection; Cell Cycle/DNA Damage
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-13231-10mM-safety-datasheet.pdf